Laboratory of Chemical Biology, Department of Biomedical Engineering, Eindhoven University of Technology, P. O. Box 513, 5600MB Eindhoven, The Netherlands.
Org Biomol Chem. 2013 Nov 28;11(44):7642-9. doi: 10.1039/c3ob41315b. Epub 2013 Oct 4.
Detection of antibodies is essential for the diagnosis of many disease states, including infectious diseases, autoimmune diseases and allergies. Most current antibody detection assays involve multistep detection schemes in which molecular recognition and signal generation are separate processes. A well-known example is the enzyme-linked immunosorbent assay (ELISA), which combines high sensitivity and specificity with strong signal amplification. However, ELISA and other heterogeneous methods require multiple, time-consuming washing and incubation steps, which limits their applicability in point-of-care diagnostics and high-throughput applications. In recent years, several new antibody detection strategies have been developed in which antibody binding and signal generation are integrated within a single biomolecular reporter. These strategies aim to rival ELISA in terms of sensitivity and specificity, while decreasing the time and effort required to perform an assay. Here, we review recent developments in this field according to their mechanism of action and discuss their advantages and limitations.
抗体检测对于许多疾病状态的诊断至关重要,包括传染病、自身免疫性疾病和过敏反应。目前大多数抗体检测方法都涉及多步检测方案,其中分子识别和信号生成是两个独立的过程。酶联免疫吸附测定(ELISA)就是一个众所周知的例子,它将高灵敏度和特异性与强大的信号放大相结合。然而,ELISA 和其他异质方法需要多次耗时的洗涤和孵育步骤,这限制了它们在即时诊断和高通量应用中的适用性。近年来,已经开发出了几种新的抗体检测策略,其中抗体结合和信号生成在单个生物分子报告物内得到了整合。这些策略旨在在灵敏度和特异性方面与 ELISA 相媲美,同时减少进行检测所需的时间和精力。在这里,我们根据其作用机制综述了该领域的最新进展,并讨论了它们的优点和局限性。